Gu Yannan, Feng Xiaodan, Jin Yanqi, Liu Yuanlin, Zeng Li, Zhou Dachun, Feng Yuling
Department of Obstetrics and Gynecology, Affiliated Maternal and Child Health Hospital of Nantong University, Nantong, China.
J Obstet Gynaecol. 2023 Dec;43(1):2171283. doi: 10.1080/01443615.2023.2171283.
Cervical cancer (CC) is a common malignant neoplasm in gynecology. There is increasing evidence to suggest that microRNAs (miRNAs) act as crucial regulators of CC. However, whether miR-10a-5p plays a role in CC is under investigation. The aim of this stuy was to assess the miR-10a-5p expression pattern in the development of CC and investigate its downstream target. MiR-10a-5p inhibition decreased CC cell proliferation and impaired CC cell invasion and migration but enhanced apoptosis. UBE2I was a direct target of miR-10a-5p. QRT-PCR results showed a down-regulation of UBE2I in CC cells, opposing miR-10a-5p. Besides, overexpression of miR-10a-5p down-regulated UBE2I. Functional rescue experiments further indicated the miR-10a-5p-UBE2I axis was linked to CC cell growth, apoptosis and metastasis. MiR-10a-5p upregulation promotes cervical cancer development by inhibiting UBE2I. These results also predict that miR-10a-5p may be a potential target for the clinical treatment of CC.IMPACT STATEMENT As a widely researched cancer-related miRNA, the overexpression of miR-10a-5p has been verified in various cancers. It has been described in a meta-analysis report that there were 42 miRNAs up-regulated and 21 miRNAs down-regulated in different stages of cervical cancer tissue versus healthy tissue. We verified that miR-10a-5p initiates and promotes tumor cell development by decreasing UBE2I abundance. This miR-10a-5p-mediated post-transcriptional regulation of UBE2I is involved in the tumorigenesis, invasion and migration of human cervical cancer. These findings provide mechanistic insights into how miR-10a-5p regulates cervical cancer hyper-proliferation and metastasis, as well as a new target for clinical treatment. Nevertheless, whether miR-10a-5p/UBE2I axis can be regulated by non-invasive methods need further exploration, which will be the focus of our future research.
宫颈癌(CC)是妇科常见的恶性肿瘤。越来越多的证据表明,微小RNA(miRNA)是宫颈癌的关键调节因子。然而,miR-10a-5p是否在宫颈癌中发挥作用仍在研究中。本研究的目的是评估miR-10a-5p在宫颈癌发生发展中的表达模式,并研究其下游靶点。抑制miR-10a-5p可降低宫颈癌细胞增殖,削弱宫颈癌细胞的侵袭和迁移能力,但可增强细胞凋亡。泛素结合酶E2I(UBE2I)是miR-10a-5p的直接靶点。实时定量聚合酶链反应(QRT-PCR)结果显示,宫颈癌细胞中UBE2I表达下调,与miR-10a-5p表达相反。此外,miR-10a-5p过表达可下调UBE2I。功能挽救实验进一步表明,miR-10a-5p-UBE2I轴与宫颈癌细胞的生长、凋亡和转移有关。miR-10a-5p上调通过抑制UBE2I促进宫颈癌发展。这些结果还预示,miR-10a-5p可能是宫颈癌临床治疗的潜在靶点。影响声明作为一种被广泛研究的癌症相关miRNA,miR-10a-5p的过表达已在多种癌症中得到证实。一项荟萃分析报告称,与健康组织相比,宫颈癌组织不同阶段有42种miRNA上调,21种miRNA下调。我们证实,miR-10a-5p通过降低UBE2I丰度启动并促进肿瘤细胞发展。这种miR-10a-5p介导的UBE2I转录后调控参与了人类宫颈癌的发生、侵袭和迁移。这些发现为miR-10a-5p如何调节宫颈癌过度增殖和转移提供了机制性见解,也为临床治疗提供了新靶点。然而,miR-10a-5p/UBE2I轴是否可通过非侵入性方法进行调控仍需进一步探索,这将是我们未来研究的重点。